Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Theralase nets $Cdn7.4mm in FOPO

04 Mar 2015

Executive Summary

Therapeutic medical laser company Theralase Technologies Inc. publicly sold 18.2mm shares at $Cdn0.44 to net $Cdn7.4mm ($5.9mm). Investors also received 60-month warrants to buy 18.2mm shares at $Cdn54. Existing stockholders purchased approximated 179 shares.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Laser
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By